Post‐Synthetic Modification of Triplex‐Forming Oligonucleotides Containing 2‐Aminoethyl‐2′‐Deoxynebularine Derivatives

Author:

Notomi Ryotaro1,Sasaki Shigeki2,Taniguchi Yosuke1

Affiliation:

1. Graduate School of Pharmaceutical Sciences Kyushu University Fukuoka Japan

2. Graduate School of Pharmaceutical Sciences Nagasaki International University Nagasaki Japan

Abstract

AbstractThis article describes the detailed synthetic protocol for the preparation of oligonucleotides containing 2‐guanidinoethyl‐2′‐deoxynebularine and 2‐ureidoethyl‐2′‐deoxynebularine nucleoside derivatives. These derivatives are obtained by a post‐synthetic modification of triplex‐forming oligonucleotides (TFOs) containing 2‐aminoethyl‐2′‐deoxynebularine, which is useful for forming stable triplex DNA with duplex DNA sequences containing 5mCG and CG interrupting sites. The hydroxyl groups of the sugar moiety of commercially available 2′‐deoxyguanosine are acetyl‐protected, the 6‐position is chlorinated and reduced to give a 2‐substituted nebularine derivative, and then the sugar moiety is deprotected. The hydroxyl groups of the sugar moiety are silyl‐protected and the amino group at the 2‐position is iodinated before being coupled with diethyl malonate. The ethyl ester is reduced and the resulting alcohol converted to an amino group for protection. The compound is then converted to a phosphoramidite unit and incorporated into a TFO. Subsequent modification of the aminoethyl group on the TFO completes the synthesis of the oligonucleotides containing 2‐guanidinoethyl‐2′‐deoxynebularine and 2‐ureidoethyl‐2′‐deoxynebularine. © 2023 Wiley Periodicals LLC.Basic Protocol 1: Preparation of the phosphoramidite unit of the 2‐aminoethyl‐2′‐deoxynebularine derivative (14)Basic Protocol 2: Post‐synthetic modification of oligonucleotides containing 2‐aminoethyl‐2′‐deoxynebularine derivativesBasic Protocol 3: Determination of the triplex‐forming ability of oligonucleotides containing 2‐aminoethyl‐2′‐deoxynebularine derivatives

Funder

Japan Society for the Promotion of Science

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Medical Laboratory Technology,Health Informatics,General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3